PDE4D7 TR-FRET Assay Kit
Phosphodiesterases (PDEs) play an important role in dynamic regulation of cAMP and cGMP signaling. PDE4D is a regulator of airway smooth-muscle contractility, and has been identified as a potential risk predictor for ischemic stroke. Additionally, PDE4D has been associated with asthma pathophysiology and bone formation. The PDE4D gene encodes at least 9 different isoforms.
The PDE4D7 TR-FRET Assay Kit is designed for identification of inhibitors of PDE4D7 using TR-FRET (Time Resolved Fluorescence Resonance Energy Transfer) technology. The assay is based on the generation of FAM-labeled nucleotide monophosphates by the phosphodiesterase. These phosphate groups bind to terbium-labeled nanoparticles, resulting in energy transfer from the terbium to the FAM, which emits a fluorescent signal at 520 nm. The change in fluorescent intensity can be easily measured using a fluorescence plate reader.
Using this kit, only two simple steps on a microtiter plate are required for the PDE4D7 activity assay. First, the fluorescent-labeled cAMP is incubated with a sample containing PDE4D7 for 1 hour. Second, a binding agent and a terbium donor are added to the reaction mix and incubated for 1 hour. Then, fluorescence intensity can be measured using a fluorescence reader.
Fluorescent microplate reader capable of measuring Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET)
Catalog # | Component | Amount | Storage | |
60047 | PDE4D7 recombinant enzyme | 1 µg | -80°C | Avoid freeze/ thaw cycles |
60200 | FAM-Cyclic-3′, 5′-AMP: 20 µM | 50 µl | -20°C | |
60393 | PDE assay buffer | 25 ml | -80°C | |
60394 | Tb donor | 50 µl | -80°C | |
60390 | Binding Agent | 200 µl | +4°C | |
78422 | Binding Buffer A | 20 ml | +4°C | |
78423 | Binding Buffer B | 20 ml | +4°C | |
79685 | Black, low binding microtiter plate | 1 | Room Temp |